Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV/ AIDS cohort study, 2006 to 2013
2
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
Background/Aims: The frequencies of opportunistic diseases (ODs) vary across countries based on genetic, environmental, and social differences. The Korean HIV/AIDS cohort study was initiated in 2006 to promote research on human immunodeficiency virus (HIV) infection in Korea, and to provide a logistical network to support multicenter projects on epidemiological, clinical, and laboratory aspects of HIV infection. This study evaluated the prevalence of ODs among HIV-infected patients in the era of highly active antiretroviral therapy, and the risk factors associated with ODs. Methods: The study enrolled 1,086 HIV-infected patients from 19 hospitals. This study examined the baseline data of the HIV/AIDS Korean cohort study at the time of enrollment from December 2006 to July 2013. Results: Candidiasis was the most prevalent opportunistic infection (n = 176, 16.2%), followed by Mycobacterium tuberculosis infection (n = 120, 10.9%), Pneumocystis jirovecii pneumonia (n = 121, 11.0%), cytomegalovirus infection (n = 52, 4.7%), and herpes zoster (n = 44, 4.0%). The prevalence rates of Kaposi’s sarcoma (n = 8, 0.7%) and toxoplasmosis (n = 4, 0.4%) were very low compared with other countries. The risk factors for ODs were a low CD4 T cell count at the time of HIV diagnosis (odds ratio [OR], 1.01; p < 0.01), current smoking (OR, 2.27; p = 0.01), current alcohol use (OR, 2.57; p = 0.04), and a history of tuberculosis (OR, 5.23; p < 0.01). Conclusions: Using recent Korean nationwide data, this study demonstrated that an important predictor of ODs was a low CD4 T cell count at the time of HIV diagnosis. Tuberculosis remains one of the most important ODs in HIV-infected patients in Korea.
Abstract
Background/Aims: The frequencies of opportunistic diseases (ODs) vary across countries based on genetic, environmental, and social differences. The Korean HIV/AIDS cohort study was initiated in 2006 to promote research on human immunodeficiency virus (HIV) infection in Korea, and to provide a logistical network to support multicenter projects on epidemiological, clinical, and laboratory aspects of HIV infection. This study evaluated the prevalence of ODs among HIV-infected patients in the era of highly active antiretroviral therapy, and the risk factors associated with ODs. Methods: The study enrolled 1,086 HIV-infected patients from 19 hospitals. This study examined the baseline data of the HIV/AIDS Korean cohort study at the time of enrollment from December 2006 to July 2013. Results: Candidiasis was the most prevalent opportunistic infection (n = 176, 16.2%), followed by Mycobacterium tuberculosis infection (n = 120, 10.9%), Pneumocystis jirovecii pneumonia (n = 121, 11.0%), cytomegalovirus infection (n = 52, 4.7%), and herpes zoster (n = 44, 4.0%). The prevalence rates of Kaposi’s sarcoma (n = 8, 0.7%) and toxoplasmosis (n = 4, 0.4%) were very low compared with other countries. The risk factors for ODs were a low CD4 T cell count at the time of HIV diagnosis (odds ratio [OR], 1.01; p < 0.01), current smoking (OR, 2.27; p = 0.01), current alcohol use (OR, 2.57; p = 0.04), and a history of tuberculosis (OR, 5.23; p < 0.01). Conclusions: Using recent Korean nationwide data, this study demonstrated that an important predictor of ODs was a low CD4 T cell count at the time of HIV diagnosis. Tuberculosis remains one of the most important ODs in HIV-infected patients in Korea.
참고문헌 (23)
- "Global health observatory data repository" (2015)[URL]
- Buchacz K, "AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study", AIDS, 24, pp.1549~1559 (2010)
- Schwarcz L, "Declining incidence of AIDS-defining opportunistic illnesses:results from 16 years of population-based AIDS surveillance", AIDS, 27, pp.597~605 (2013)
- JuneMyung Kim, "Epidemiology and Clinical Features of HIV Infection", AIDS in Korea, 2003, pp.44(3), 363~370[DOI]
- Oh MD, "Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea", Clin Infect Dis, 29, pp.1524~1528 (1999)
- 대한에이즈학회, "국내 HIV 감염인의 기회감염증 치료와 예방에 관한 임상진료지침 권고안", Infection and Chemotherapy, 44(3), pp.93~139 (2012), 대한감염학회[DOI]
- Joint Committee for the Development of Korean Guideline for Tuberculosis, "Korean guidelines for tuberculosis. 1st ed", Korea Centers for Disease Control and Prevention, ~ (2011)
- Seage GR 3rd, "The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 cell counts to chronic mortality", J Acquir Immune Defic Syndr, 30, pp.421~428 (2002)
- Egger M, "Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study", BMJ, 315, pp.1194~1199 (1997)
- Damtie D, "Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia", BMC Res Notes, 6, pp.534~ (2013)
- Xiao J, "Spectrums of opportunistic infections and malignancies in HIV-infected patients in tertiary care hospital, China", PLoS One, 8, pp.e75915~ (2013)
- Hanna DB, "AIDS-defining opportunistic illnesses in the HAART era in New York City", AIDS Care, 19, pp.264~272 (2007)
- Narain JP, "Epidemiology of HIV-TB in Asia", Indian J Med Res, 120, pp.277~289 (2004)
- Ledergerber B, "Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study", Lancet, 353, pp.863~868 (1999)
- Nagai H, "Factors for the onset of and the exacerbation of tuberculosis. 5. The infection and prognosis of tuberculosis among patients with immunodeficiency, especially HIV-infected patients", Kekkaku, 74, pp.753~758 (1999)
- Moreno S, "Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status", Int J Tuberc Lung Dis, 12, pp.1393~1400 (2008)
- Sterling TR, "Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening", J Infect Dis, 204, pp.893~901 (2011)
- Seyler C, "Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan", Am J Respir Crit Care Med, 172, pp.123~127 (2005)
- de Sanjose S, "Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission", J Infect Dis, 199, pp.1449~1456 (2009)
- Manosuthi W, "Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting", J Infect, 55, pp.464~469 (2007)
- 차혁환, "처음 의료기관을 내원하는 노숙 Human immunodeficiency virus 감염인의 질병 진행 정도", Infection and Chemotherapy, 43(2), pp.198~202 (2011), 대한감염학회
- Chattopadhyay A, "Smoking as a risk factor for oral candidiasis in HIV-infected adults", J Oral Pathol Med, 42, pp.302~308 (2013)
- Chattopadhyay A, "Risk indicators for HIV-associated jointly occurring oral candidiasis and oral hairy leukoplakia", AIDS Patient Care STDS, 21, pp.825~832 (2007)